{
    "2019-04-24": [
        [
            {
                "time": "2019-04-24",
                "original_text": "Lannett (LCI) to Report Q3 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Lannett",
                        "Q3 Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q1 Earnings",
                        "Beat Estimates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "After Hours Most Active for Apr 24, 2019 : PCG, MSFT, FB, SNAP, CMCSA, XOG, FOLD, SHY, PFE, RF, CNDT, POL",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Most Active",
                        "PFE"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Why Investors Should Buy the Dip in MRK Stock",
                "features": {
                    "keywords": [
                        "Investors",
                        "Buy the Dip",
                        "MRK Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "PFE"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "What Are Analysts Recommending for Merck?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommending",
                        "Merck"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "AstraZeneca chief claims vindication five years after Pfizer bid",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "vindication",
                        "Pfizer bid"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}